Skip to main content

Doxorubicin News

FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma

October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS),...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Acute Lymphoblastic Leukemia, Cancer, Diffuse Large B-Cell Lymphoma, Lymphoma, Multiple Myeloma, Ovarian Cancer, Thyroid Cancer

Doxorubicin patient information at Drugs.com